Clinical Trial

Life at 100.4: An Immersive Social Virtual Reality (VR) Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to design and Beta test the Life at 100.4, an immersive social virtual reality education tool, with an anticipated 5 patient-caregiver-provider triads.Patients at Yale Pediatric Hematology and Oncology with a new oncologic diagnosis and their caregivers will be eligible for enrollment. Investigators will determine the feasibility and acceptability of implementing Life at 100.4 using validated measures.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-10-31.
Status change: Not Yet Recruiting → Recruiting 2026-02-24
Trial Details
NCT Number NCT07224204
Lead Sponsor Yale University
Collaborators: The Glimpse Group Inc, National Institute of Nursing Research (NINR)
Conditions Cancer, Adolescent Cancer, Young Adult Cancer
Enrollment 45 participants
Start Date 2026-02-11
Primary Completion 2027-04 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2026-02-25